Evidence map›Paper›PMID 41661824›Full record

ArticlePLOS mental health2024

Moderation of the real-world effectiveness of smoking cessation aids by mental health conditions: A population study.

Sarah E Jackson, Leonie Brose, Vera Buss, Lion Shahab, Deborah Robson, Jamie Brown

Abstract read
In one paragraph

Article in PLOS mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Prevalence of Nicotine Pouch Use Among Youth and Adults in Great Britain-Analysis of Cross-Sectional, Nationally Representative Surveys.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah E JacksonDepartment of Behavioural Science and Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-5658-6168
Leonie BroseSPECTRUM Consortium, London, United Kingdom.ORCID https://orcid.org/0000-0001-6503-6854
Vera BussDepartment of Behavioural Science and Health, University College London, London, United Kingdom.
Lion ShahabDepartment of Behavioural Science and Health, University College London, London, United Kingdom.
Deborah RobsonSPECTRUM Consortium, London, United Kingdom.
Jamie BrownDepartment of Behavioural Science and Health, University College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine whether the real-world effectiveness of popular smoking cessation aids differs between users with and without a history of mental health conditions.

designNationally-representative cross-sectional survey conducted monthly between 2016-17 and 2020-23.

settingEngland.

participants5,593 adults (2,524 with a history of ≥1 mental health conditions and 3,069 without) who had smoked regularly within the past year and had attempted to quit at least once in the past year.

main outcome measuresThe outcome was self-reported abstinence from quit date up to the survey. Independent variables were use of the following cessation aids during the most recent quit attempt: prescription nicotine replacement therapy (NRT), NRT over-the-counter, varenicline, bupropion, vaping products, face-to-face behavioural support, telephone support, written self-help materials, websites, hypnotherapy, Allen Carr's Easyway, heated tobacco products, and nicotine pouches. The moderator was history of diagnosed mental health conditions (yes/no). Covariates included sociodemographic characteristics, level of cigarette addiction, and characteristics of the quit attempt.

resultsRelative to those without, participants with a history of mental health conditions were significantly more likely to report using vaping products (38.8% [95%CI 36.7-40.8] vs. 30.7% [28.9-32.5]), prescription NRT (4.8% [3.9-5.7] vs. 2.7% [2.1-3.3]), and websites (4.0% [3.2-4.8] vs. 2.2% [1.6-2.7]). Groups did not differ significantly in their use of other aids. After adjusting for covariates and use of other cessation aids, those who used vaping products (OR = 1.92, 95%CI 1.61-2.30), varenicline (OR = 1.88, 95%CI 1.19-2.98), or heated tobacco products (OR = 2.33, 95%CI 1.01-5.35) had significantly higher odds of quitting successfully than those who did not report using these aids. There was little evidence that using other cessation aids increased the odds of successful cessation, or that the user's history of mental health conditions moderated the effectiveness of any aid.

conclusionsUse of vaping products, varenicline, or heated tobacco products in a quit attempt was associated with significantly greater odds of successful cessation, after adjustment for use of other cessation aids and potential confounders. There was no evidence to suggest the effectiveness of any popular cessation aid differed according to the user's history of mental health conditions.

Identifiers

PMID41661824
PMCPMC12798440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.